Jianmei Hou

810 total citations
17 papers, 646 citations indexed

About

Jianmei Hou is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jianmei Hou has authored 17 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Jianmei Hou's work include Angiogenesis and VEGF in Cancer (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Microtubule and mitosis dynamics (2 papers). Jianmei Hou is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Microtubule and mitosis dynamics (2 papers). Jianmei Hou collaborates with scholars based in China, Australia and United Kingdom. Jianmei Hou's co-authors include Fiona Blackhall, Caroline Dive, Lee Lancashire, Robert Szczepaniak‐Sloane, Lynsey Priest, Daisuke Nonaka, Glen Clack, Alison Backen, Malcolm Ranson and Matthew Krebs and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and FEBS Letters.

In The Last Decade

Jianmei Hou

17 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianmei Hou China 9 448 264 191 169 86 17 646
Nina Gottschalk Germany 9 409 0.9× 268 1.0× 145 0.8× 280 1.7× 74 0.9× 23 725
Wei Yin China 11 430 1.0× 274 1.0× 169 0.9× 213 1.3× 39 0.5× 22 651
Zhouyu Ning China 19 364 0.8× 357 1.4× 134 0.7× 500 3.0× 87 1.0× 40 911
Eleonora Lai Italy 14 315 0.7× 154 0.6× 145 0.8× 205 1.2× 93 1.1× 46 572
Joëlle Collignon Belgium 12 285 0.6× 257 1.0× 127 0.7× 383 2.3× 46 0.5× 59 699
Xinghua Han China 15 224 0.5× 289 1.1× 168 0.9× 349 2.1× 66 0.8× 54 676
Margo P. Cain United States 6 199 0.4× 236 0.9× 154 0.8× 389 2.3× 98 1.1× 6 692
Hend Ahmed El-Hadaad Egypt 9 243 0.5× 140 0.5× 105 0.5× 241 1.4× 52 0.6× 25 552
Caiwen Du China 15 416 0.9× 250 0.9× 168 0.9× 473 2.8× 92 1.1× 45 803

Countries citing papers authored by Jianmei Hou

Since Specialization
Citations

This map shows the geographic impact of Jianmei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianmei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianmei Hou more than expected).

Fields of papers citing papers by Jianmei Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianmei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianmei Hou. The network helps show where Jianmei Hou may publish in the future.

Co-authorship network of co-authors of Jianmei Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Jianmei Hou. A scholar is included among the top collaborators of Jianmei Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianmei Hou. Jianmei Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Roy, Michael J., Jianmei Hou, Weiwen Dai, et al.. (2023). Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. Nature Communications. 14(1). 3542–3542. 10 indexed citations
2.
Hou, Jianmei, Elizabeth V. Nguyen, Michael J. Roy, et al.. (2022). Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family. Science Signaling. 15(722). eabj3554–eabj3554. 7 indexed citations
3.
4.
Hou, Jianmei, Xudong Wang, Li Yang, et al.. (2012). 17beta‐estradiol induces both up‐regulation and processing of cyclin E in a calpain‐dependent manner in MCF‐7 breast cancer cells. FEBS Letters. 586(6). 892–896. 8 indexed citations
5.
Krebs, Matthew, Jianmei Hou, Robert Szczepaniak‐Sloane, et al.. (2011). Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches. Journal of Thoracic Oncology. 7(2). 306–315. 371 indexed citations
6.
Tan, Benxu, Ye Chen, Li V. Yang, et al.. (2011). Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. Journal of Molecular Medicine. 89(6). 595–602. 66 indexed citations
7.
Cheng, Ke, Yang Wu, Xingchen Peng, et al.. (2011). Interleukin-15 enhances T-cell responses by stimulation with dendritic cells. Clinical & Translational Oncology. 13(4). 275–280. 3 indexed citations
8.
Gong, Fengming, Xingchen Peng, Benxu Tan, et al.. (2011). Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart. Anti-Cancer Drugs. 22(6). 500–506. 7 indexed citations
9.
Stovold, Rachel, et al.. (2011). Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells. Lung Cancer. 76(3). 263–268. 42 indexed citations
10.
Hou, Jianmei, Xia Zhao, Ling Tian, et al.. (2009). Immunotherapy of tumors with recombinant adenovirus encoding macrophage inflammatory protein 3β induces tumor-specific immune response in immunocompetent tumor-bearing mice. Acta Pharmacologica Sinica. 30(3). 355–363. 8 indexed citations
11.
Tian, Ling, Jianmei Hou, Yongsheng Wang, et al.. (2006). Expression of extracellular domain of human vascular endothelial growth factor receptor-2 in Pichia pastoris.. PubMed. 37(1). 1–4. 1 indexed citations
12.
13.
Yao, Bin, Qiuming He, Ling Tian, et al.. (2005). Enhanced Antitumor Effect of the Combination of Tumstatin Gene Therapy and Gemcitabine in Murine Models. Human Gene Therapy. 0(0). 2304761025–2304761025. 3 indexed citations
14.
Yao, Bin, Qiuming He, Ling Tian, et al.. (2005). Enhanced Antitumor Effect of the Combination of Tumstatin Gene Therapy and Gemcitabine in Murine Models. Human Gene Therapy. 16(9). 1075–1086. 20 indexed citations
15.
Li, Gang, Ling Tian, Jianmei Hou, et al.. (2005). Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors. Clinical Cancer Research. 11(11). 4217–4224. 59 indexed citations
16.
Hou, Jianmei. (2004). Immunotherapy of tumor by targeting angiogenesis. Science in China Series C Life Sciences. 47(6). 545–545. 1 indexed citations
17.
Hou, Jianmei, Ling Tian, & Yuquan Wei. (2004). Cancer immunotherapy of targeting angiogenesis.. PubMed. 1(3). 161–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Gottschalk Breakdown of academic impact, for papers by Wei Yin Breakdown of academic impact, for papers by Zhouyu Ning Breakdown of academic impact, for papers by Eleonora Lai Breakdown of academic impact, for papers by Joëlle Collignon Breakdown of academic impact, for papers by Xinghua Han Breakdown of academic impact, for papers by Margo P. Cain Breakdown of academic impact, for papers by Hend Ahmed El-Hadaad Breakdown of academic impact, for papers by Caiwen Du
Rankless by CCL
2026